-+ 0.00%
-+ 0.00%
-+ 0.00%

AGIOS PHARMA SHARES DOWN 12.5% PREMARKET AS FDA EXTENDS REVIEW OF DRUG FOR SICKLE CELL DISEASE

Reuters·10/30/2026 13:16:06